Should we stop prescribing metoclopramide as a prokinetic drug in critically ill patients?

Regulatory agencies in North America and Europe recently re-evaluated the safety of metoclopramide. This re-evaluation resulted in recommendations and restrictions in order to minimise the risk of neurological and other adverse reactions associated with the use of metoclopramide. In the ICU, off-lab...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Meer, Y Gert, Venhuizen, Willem A, Heyland, Daren K, van Zanten, Arthur RH
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Viewpoint
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331179/
https://www.ncbi.nlm.nih.gov/pubmed/25672546
http://dx.doi.org/10.1186/s13054-014-0502-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4331179/
https://www.ncbi.nlm.nih.gov/pubmed/25672546
http://dx.doi.org/10.1186/s13054-014-0502-4

Ejemplares similares